Results 161 to 170 of about 376,311 (300)

Multi-View Learning to Unravel the Different Levels Underlying Hepatitis B Vaccine Response. [PDF]

Vaccines (Basel), 2023
Affaticati F, Bartholomeus E, Mullan K, Damme PV, Beutels P, Ogunjimi B, Laukens K, Meysman P.   +7 more
europepmc   +1 more source

Mapping disasters; the application of a disaster-sociological 'Theoretical superstructure' and methodology in a Prima Facie case for investigating the role of hepatitis B vaccines in the contamination of the Canadian blood supply with human immunodef [PDF]

, 2000
Olaf Krassnitzky
openalex   +1 more source

Anticipating Knowledge Applicability in Open Science Through Recycling, Mimicking, and Shortcutting

R&D Management, EarlyView.
ABSTRACT Open science literature scrutinizes how organizations provide access to knowledge. Yet, much less is known about how organizations pursuing open science for societal impact anticipate knowledge applicability—that shared knowledge is reusable for other organizations and individuals, and enables open social innovation.
Konstantin Hondros, Milena Leybold, Leonhard Dobusch, Sigrid Quack   +3 more
wiley   +1 more source

A real-world pharmacovigilance analysis of hepatitis B vaccine using the U.S. Vaccine Adverse Event Reporting System (VAERS) database. [PDF]

Sci Rep
Zhou H, Yang J, Zhang J, Liu P, Yao D.
europepmc   +1 more source

Hepatitis B Vaccine and Multiple Sclerosis: Cause or Coincidence. [PDF]

Cureus, 2022
Luhadia K, Abugrin M, Kiani R, Ahmady A, Virk J, Yashi K.   +5 more
europepmc   +1 more source

FRI0248 Myasthenia gravis after hepatitis b vaccine. report of one case [PDF]

, 2001
ME Bahri, B. Louzir, S. Othmani, R. Battikh, MO Bahri   +4 more
openalex   +1 more source

Immunogenicity of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in nonresponders to licensed hepatitis B vaccine

Human Vaccines & Immunotherapeutics, 2013
Scott A. Halperin, Brian J. Ward, Marc S Dionne, J. M. Langley, Shelly A. McNeil, Bruce Smith, D. MacKinnon-Cameron, William L. Heyward, J. Martin   +8 more
semanticscholar   +1 more source

Simulation model to estimate the burden of disease due to hepatitis E virus in Dutch pig meat and cost‐effectiveness of control measures

Risk Analysis, EarlyView.
Abstract Hepatitis E virus (HEV) can lead to liver disease in humans. In the Netherlands, the consumption of pig meat is thought to be the main contributor to the total burden of disease caused by HEV. In this study, the number of cases and lost disability‐adjusted‐life‐years (DALYs) due to HEV in pig meat were estimated by simulating HEV through the ...
M. Focker, C. P. A. van Wagenberg, M. A. P. M. van Asseldonk, I. L. A. Boxman, R. W. Hakze ‐ van der Honing, E. D. van Asselt   +5 more
wiley   +1 more source

A Comprehensive Review of Hepatitis B Vaccine Nonresponse and Associated Risk Factors. [PDF]

Vaccines (Basel)
Tahir A, Shinkafi SH, Alshrari AS, Yunusa A, Umar MT, Hudu SA, Jimoh AO.   +6 more
europepmc   +1 more source

Now is the Time to Scale Up Birth-Dose Hepatitis B Vaccine in Low- and Middle-Income Countries. [PDF]

J Infect Dis, 2023
Thompson P, Parr JB, Boisson A, Razavi-Shearer D, Ezechi OC, Wang SH, Tucker JD.   +6 more
europepmc   +1 more source